The Senate has unanimously approved the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act.
Monoclonal antibodies provide small benefits in Alzheimer’s disease
Jan 26, 2024
Harms include increased risks for amyloid-related imaging abnormalities (ARIA)-edema, ARIA-hemorrhage and symptomatic ARIA-edema.
Alzheimer’s disease risk up for older adults after COVID-19 infection
Sep 14, 2022
The highest risk for a new diagnosis of Alzheimer’s disease within 360 days after diagnosis was seen for those aged 85 years and older and women.
Telmisartan linked to reduced risk for Alzheimer’s disease in Black patients
Nov 07, 2022
Black-specific beneficial effects of telmisartan were identified in a Mendelian randomization analysis.
Providers identify 5 key areas for person-centered care of residents with dementia
By
Kimberly Bonvissuto
Nov 19, 2020
Several senior living companies were part of a roundtable that helped researchers identify five areas of change and developed person-centered practical solutions to address the unmet needs of people with...
Reason for hope as World Alzheimer’s Month continues
By
Lois A. Bowers
Sep 23, 2019
Days before World Alzheimer’s Day, which was Saturday, some bad news arrived about the search for a treatment. But there still are reasons for hope in the battle against Alzheimer’s.
Higher education may protect functioning with Alzheimer’s disease
Apr 03, 2024
The findings were seen among African American individuals, with greater protective effect in APOE ɛ4 noncarriers.